Ocugen, Inc. short interest in 2021
In 2021, Ocugen, Inc.'s disclosed short interest ran from 7.00% of shares outstanding on 29 Jan 2021 to 27.72% on 31 Dec 2021, a change of +20.72 percentage points. The year's high was 28.67% on 15 Oct 2021 and its low 5.03% on 12 Feb 2021, averaging 21.52% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.69 days on 31 Aug 2021. Full history: Ocugen, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 7.00% (29 Jan 2021)
- End of year
- 27.72% (31 Dec 2021)
- Change
- +20.72 pp
- High
- 28.67% (15 Oct 2021)
- Low
- 5.03% (12 Feb 2021)
- Average
- 21.52%
- Highest days to cover
- 6.69 (31 Aug 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 29 Jan 2021 | 7.00% | 1.00 | |
| 12 Feb 2021 | 5.03% | 1.00 | |
| 26 Feb 2021 | 7.67% | 1.00 | |
| 15 Mar 2021 | 8.03% | 1.00 | |
| 31 Mar 2021 | 16.74% | 1.59 | results (8-K), 10-K filed |
| 15 Apr 2021 | 21.46% | 1.62 | |
| 30 Apr 2021 | 18.68% | 1.00 | |
| 14 May 2021 | 19.21% | 1.00 | 10-Q filed, results (8-K) |
| 28 May 2021 | 21.68% | 1.29 | |
| 15 Jun 2021 | 24.87% | 1.00 | |
| 30 Jun 2021 | 25.52% | 1.50 | |
| 15 Jul 2021 | 26.36% | 2.76 | |
| 30 Jul 2021 | 26.86% | 3.55 | |
| 13 Aug 2021 | 27.26% | 2.81 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 25.70% | 6.69 | |
| 15 Sep 2021 | 26.54% | 3.42 | |
| 30 Sep 2021 | 26.71% | 5.38 | |
| 15 Oct 2021 | 28.67% | 1.77 | |
| 29 Oct 2021 | 27.56% | 1.10 | |
| 15 Nov 2021 | 23.56% | 1.00 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 24.84% | 3.01 | |
| 15 Dec 2021 | 27.26% | 3.34 | |
| 31 Dec 2021 | 27.72% | 3.79 |
See also: Ocugen, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.